Proteome Sciences PLC (PRM) - Total Assets

Latest as of December 2025: GBX8.26 Million GBX ≈ $1.00K USD

Based on the latest financial reports, Proteome Sciences PLC (PRM) holds total assets worth GBX8.26 Million GBX (≈ $1.00K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Proteome Sciences PLC - Total Assets Trend (1994–2025)

This chart illustrates how Proteome Sciences PLC's total assets have evolved over time, based on quarterly financial data. Also see how much is Proteome Sciences PLC worth for the company's overall valuation and market capitalisation.

Proteome Sciences PLC - Asset Composition Analysis

Current Asset Composition (December 2025)

Proteome Sciences PLC's total assets of GBX8.26 Million consist of 25.1% current assets and 74.9% non-current assets. Review debt load of Proteome Sciences PLC to assess the company's total debt and financial obligations.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	9.5%
Accounts Receivable	GBX754.00K	9.1%
Inventory	GBX537.00K	6.5%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX0.00	0.0%
Goodwill	GBX4.22 Million	51.1%

Asset Composition Trend (1994–2025)

This chart illustrates how Proteome Sciences PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See PRM stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Proteome Sciences PLC's current assets represent 25.1% of total assets in 2025, a decrease from 87.6% in 1994.
Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, down from 84.5% in 1994.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 0.0% in 1994.
Asset Diversification: The largest asset category is goodwill at 51.1% of total assets.

Proteome Sciences PLC Competitors by Total Assets

Key competitors of Proteome Sciences PLC based on total assets are shown below.

Company	Country	Total Assets
Medpace Holdings Inc NASDAQ:MEDP	USA	$2.06 Billion
Chemclin Diagnostics Co. Ltd. A SHG:688468	China	CN¥1.76 Billion
Genetic Signatures Ltd AU:GSS	Australia	AU$49.04 Million
Sonic Healthcare Ltd AU:SHL	Australia	AU$16.78 Billion
Integral Diagnostics Ltd AU:IDX	Australia	AU$1.43 Billion
Australian Clinical Labs Ltd AU:ACL	Australia	AU$562.50 Million
Healius Ltd AU:HLS	Australia	AU$1.77 Billion
Monash Ivf Group Ltd AU:MVF	Australia	AU$510.21 Million

Proteome Sciences PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.13	0.18	0.37
Quick Ratio	0.09	0.13	0.30
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX-14.50 Million	GBX-11.42 Million	GBX-7.27 Million

Proteome Sciences PLC - Advanced Valuation Insights

This section examines the relationship between Proteome Sciences PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	974.68
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	-10.3%
Total Assets	GBX8.26 Million
Market Capitalization	$59.74K USD

Valuation Analysis

Below Book Valuation: The market values Proteome Sciences PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Proteome Sciences PLC's assets decreased by 10.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Proteome Sciences PLC (1994–2025)

The table below shows the annual total assets of Proteome Sciences PLC from 1994 to 2025.

Year	Total Assets	Change
2025-12-31	GBX8.26 Million ≈ $1.00K	-10.34%
2024-12-31	GBX9.21 Million ≈ $1.12K	-19.65%
2023-12-31	GBX11.46 Million ≈ $1.39K	-100.00%
2022-12-31	GBX1.51 Trillion ≈ $184.17 Million	+9.35%
2021-12-31	GBX1.38 Trillion ≈ $168.43 Million	+2.58%
2020-12-31	GBX1.35 Trillion ≈ $164.20 Million	+18.35%
2019-12-31	GBX1.14 Trillion ≈ $138.73 Million	+0.61%
2018-12-31	GBX1.13 Trillion ≈ $137.89 Million	+0.00%
2017-12-31	GBX1.13 Trillion ≈ $137.88 Million	-6.58%
2016-12-31	GBX1.21 Trillion ≈ $147.60 Million	+8.31%
2015-12-31	GBX1.12 Trillion ≈ $136.27 Million	-17.52%
2014-12-31	GBX1.36 Trillion ≈ $165.22 Million	+1.06%
2013-12-31	GBX1.34 Trillion ≈ $163.48 Million	+19332952.37%
2012-12-31	GBX6.95 Million ≈ $845.60	-36.29%
2011-12-31	GBX10.91 Million ≈ $1.33K	-30.06%
2010-12-31	GBX15.60 Million ≈ $1.90K	+151.56%
2009-12-31	GBX6.20 Million ≈ $754.36	-3.76%
2008-12-31	GBX6.44 Million ≈ $783.81	-2.88%
2007-12-31	GBX6.63 Million ≈ $807.04	+3.71%
2006-12-31	GBX6.40 Million ≈ $778.21	-33.20%
2005-12-31	GBX9.57 Million ≈ $1.17K	-7.42%
2004-12-31	GBX10.34 Million ≈ $1.26K	-28.31%
2003-12-31	GBX14.43 Million ≈ $1.76K	+4.35%
2002-12-31	GBX13.83 Million ≈ $1.68K	+268.96%
2001-12-31	GBX3.75 Million ≈ $455.90	-11.10%
2000-12-31	GBX4.21 Million ≈ $512.84	+425.56%
1999-12-31	GBX802.00K ≈ $97.58	-57.63%
1998-12-31	GBX1.89 Million ≈ $230.32	-44.63%
1997-12-31	GBX3.42 Million ≈ $415.99	+464.19%
1996-12-31	GBX606.00K ≈ $73.73	-66.90%
1995-12-31	GBX1.83 Million ≈ $222.78	+338.04%
1994-12-31	GBX418.00K ≈ $50.86	0.00%
1994-10-31	GBX418.00K ≈ $50.86	--

About Proteome Sciences PLC

LSE:PRM UK Diagnostics & Research

Market Cap

$59.74K

GBX491.01 Million GBX

Market Cap Rank

#31605 Global

#1187 in UK

Share Price

GBX1.40

Change (1 day)

-3.45%

52-Week Range

GBX1.28 - GBX3.51

All Time High

GBX22.25